164 related articles for article (PubMed ID: 3781629)
1. Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.
Schweinle JE
Infect Immun; 1986 Dec; 54(3):876-81. PubMed ID: 3781629
[TBL] [Abstract][Full Text] [Related]
2. The effects of capsular polysaccharide on the capacity of serum to support the killing of type 3 Streptococcus pneumoniae by human neutrophils.
Esposito AL; Clark CA
APMIS; 1990 Sep; 98(9):812-22. PubMed ID: 2171581
[TBL] [Abstract][Full Text] [Related]
3. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits.
Reed WP; Jaffee P; Albright EL; Williams RC
Infect Immun; 1980 Sep; 29(3):1021-7. PubMed ID: 7429626
[TBL] [Abstract][Full Text] [Related]
5. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
Giebink GS; Grebner JV; Kim Y; Quie PG
Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
[TBL] [Abstract][Full Text] [Related]
6. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis.
Simell B; Vuorela A; Ekström N; Palmu A; Reunanen A; Meri S; Käyhty H; Väkeväinen M
Vaccine; 2011 Feb; 29(10):1929-34. PubMed ID: 21236231
[TBL] [Abstract][Full Text] [Related]
7. Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6.
Mold C; Edwards KM; Gewurz H
Infect Immun; 1982 Sep; 37(3):987-92. PubMed ID: 7129640
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.
Braconier JH; Odeberg H; Sjöholm AG
Infect Immun; 1983 Apr; 40(1):219-24. PubMed ID: 6403465
[TBL] [Abstract][Full Text] [Related]
9. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.
Jansen WT; Gootjes J; Zelle M; Madore DV; Verhoef J; Snippe H; Verheul AF
Clin Diagn Lab Immunol; 1998 Sep; 5(5):703-10. PubMed ID: 9729539
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the factors contributing to the killing of type 3 Streptococcus pneumoniae by human polymorphonuclear leukocytes in vitro.
Esposito AL; Clark CA; Poirier WJ
APMIS; 1990 Feb; 98(2):111-21. PubMed ID: 2405890
[TBL] [Abstract][Full Text] [Related]
11. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
Bjornson AB; Lobel JS; Harr KS
J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
[TBL] [Abstract][Full Text] [Related]
12. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae.
Vitharsson G; Jónsdóttir I; Jónsson S; Valdimarsson H
J Infect Dis; 1994 Sep; 170(3):592-9. PubMed ID: 8077716
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
[TBL] [Abstract][Full Text] [Related]
14. Alternative Complement Pathway Inhibition Abrogates Pneumococcal Opsonophagocytosis in Vaccine-Naïve, but Not in Vaccinated Individuals.
Muri L; Ispasanie E; Schubart A; Thorburn C; Zamurovic N; Holbro T; Kammüller M; Pluschke G
Front Immunol; 2021; 12():732146. PubMed ID: 34707606
[TBL] [Abstract][Full Text] [Related]
15. Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.
Rainard P; Boulard C
Infect Immun; 1992 Nov; 60(11):4801-8. PubMed ID: 1398991
[TBL] [Abstract][Full Text] [Related]
16. Discrepancy between effects of in vivo and in vitro administration of gammaglobulin on phagocytic killing of Streptococcus pneumoniae in an antibody-deficient serum.
Braconier JH; Prellner K; Sjöholm AG
Int Arch Allergy Appl Immunol; 1988; 86(4):426-31. PubMed ID: 2457557
[TBL] [Abstract][Full Text] [Related]
17. Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3.
Fine DP; Kirk JL; Schiffman G; Schweinle JE; Guckian JC
J Lab Clin Med; 1988 Oct; 112(4):487-97. PubMed ID: 3171357
[TBL] [Abstract][Full Text] [Related]
18. Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.
Brady AM; Calix JJ; Yu J; Geno KA; Cutter GR; Nahm MH
J Infect Dis; 2014 Oct; 210(7):1155-65. PubMed ID: 24683196
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte phagocytosis and killing virulent and avirulent serotypes of Streptococcus pneumoniae.
Braconier JH; Odeberg H
J Lab Clin Med; 1982 Aug; 100(2):279-87. PubMed ID: 6284848
[TBL] [Abstract][Full Text] [Related]
20. Evidence for quantitative variability of bacterial opsonic requirements.
Guckian JC; Christensen WD; Fine DP
Infect Immun; 1978 Mar; 19(3):822-6. PubMed ID: 25243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
